Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: assessment of transduction and toxicity in long-term culture

Citation
Kl. Mackenzie et al., Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: assessment of transduction and toxicity in long-term culture, BLOOD, 96(1), 2000, pp. 100-108
Citations number
42
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
96
Issue
1
Year of publication
2000
Pages
100 - 108
Database
ISI
SICI code
0006-4971(20000701)96:1<100:AVGTTP>2.0.ZU;2-3
Abstract
Adenoviral gene transfer to primitive hematopoietic progenitor cells (HPCs) would be useful in gene therapy applications where transient, high-level t ransgene expression is required. In the present Investigations, we have use d an adenoviral vector expressing the green fluorescent protein (AdGFP) to quantify transduction of primitive HPCs and assess adenoviral-associated to xicity in long-term culture. Here we show that a cytokine cocktail protects mass populations of CD34(+) cells and primary colony forming unit-cultures (CFU-Cs) from toxicity, enabling transduction of up to 79% of CD34(+) cell s. Transduction of CFU-Cs primitive (HPCs) and more primitive HPCs was quan tified following fluorescence activated cell sorting for green flourescence protein expression, Our results demonstrate transduction of 45% of primary CFU-Cs, 33% of week-5 cobblestone area forming cells (CAFCs), and 18% of w eek-5 CFU-Cs. However, AdGFP infection inhibited proliferation of more prim itive cells. Although there was no apparent quantitative change in week-5 C AFCs, the clonogenic capacity of week-5 AdGFP-infected cells was reduced by 40% (P < .01) when compared with mock-infected cells. Adenoviral toxicity specifically affected the transduced subset of primitive HPCs. Transduction of primitive cells is therefore probably underestimated by week-5 CFU Cs a nd more accurately indicated by week-5 CAFCs. These studies provide the fir st functional and quantitative evidence of adenoviral transduction of primi tive HPCs. However, further investigations will be necessary to overcome ad enoviral toxicity toward primitive HPCs before adenoviral vectors can be co nsidered a safe option for gene therapy. (Blood. 2000;96:100-108) (C) 2000 by The American Society of Hematology.